US Public Health Gains from Improved Treatment of Hypercholesterolemia: A Simulation Study of NHANES Adults Treated to Guideline-Directed Therapy
Aligning treatment of hypercholesterolemia with US and European guidelines would generate major clinical and public health gains.
Authors
- Hemalkumar B. Mehta (ORCID: https://orcid.org/0000-0001-9134-6370)
- G. Caleb Alexander (ORCID: https://orcid.org/0000-0002-5622-2986)
- Seth S. Martin (ORCID: https://orcid.org/0000-0002-7021-7622)
- Jeromie Ballreich (ORCID: https://orcid.org/0000-0003-2564-4577)
- Alejandro Victores (ORCID: https://orcid.org/0000-0003-4988-5594)
- Erin D. Michos (ORCID: https://orcid.org/0000-0002-5547-5084)
- Jason Exter
- Xuya Xiao (ORCID: https://orcid.org/0000-0003-4198-7502)
- Lori D. Bash (ORCID: https://orcid.org/0000-0002-6036-2498)
- Kathryn Foti (ORCID: https://orcid.org/0000-0002-6380-2735)
- Shanshan Lin (ORCID: https://orcid.org/0000-0003-4695-278X)
- Jill Curran
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- University of Alabama at Birmingham (US)
Publication Details
- Journal
- Journal of General Internal Medicine
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1007/s11606-025-09625-0
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Merck